EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum NMR-Based Metabolomics Profiling Identifies Lipoprotein Subfraction Variables and Amino Acid Reshuffling in Myeloma Development and Progression

Shona Pedersen iD, Morten Faarbæk Mikkelstrup, Søren Risom Kristensen iD, Najeha Rizwana Anwardeen iD, Mohamed A Elrayess iD, Trygve Andreassen

International Journal of Molecular Sciences · 31.07.2023 · 24 (15) · 12275

DOI: 10.3390/ijms241512275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.07.2023. Verfasst von Shona Pedersen und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, QU Health, Qatar University, Doha 2713, Qatar. Hauptthemen laut MEDLINE: Multiple Myeloma, Metabolomics, Lipoproteins, Amino Acids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Obel Family Foundation, Danish Research Council for Independent Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is an incurable hematological cancer. It is preceded by monoclonal gammopathy of uncertain significance (MGUS)—an asymptomatic phase. It has been demonstrated that early detection increases the 5-year survival rate. However, blood-based biomarkers that enable early disease detection are lacking. Metabolomic and lipoprotein subfraction variable profiling is gaining traction to expand our understanding of disease states and, more specifically, for identifying diagnostic markers in patients with hematological cancers. This study aims to enhance our understanding of multiple myeloma (MM) and identify candidate metabolites, allowing for a more effective preventative treatment. Serum was collected from 25 healthy controls, 20 patients with MGUS, and 30 patients with MM. 1H-NMR (Nuclear Magnetic Resonance) spectroscopy was utilized to evaluate serum samples. The metabolite concentrations were examined using multivariate, univariate, and pathway analysis. Metabolic profiles of the MGUS patients revealed lower levels of alanine, lysine, leucine but higher levels of formic acid when compared to controls. However, metabolic profiling of MM patients, compared to controls, exhibited decreased levels of total Apolipoprotein-A1, HDL-4 Apolipoprotein-A1, HDL-4 Apolipoprotein-A2, HDL Free Cholesterol, HDL-3 Cholesterol and HDL-4 Cholesterol. Lastly, metabolic comparison between MGUS to MM patients primarily indicated alterations in lipoproteins levels: Total Cholesterol, HDL Cholesterol, HDL Free Cholesterol, Total Apolipoprotein-A1, HDL Apolipoprotein-A1, HDL-4 Apolipoprotein-A1 and HDL-4 Phospholipids. This study provides novel insights into the serum metabolic and lipoprotein subfraction changes in patients as they progress from a healthy state to MGUS to MM, which may allow for earlier clinical detection and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaMetabolomicsLipoproteinsAmino AcidsHumansMaleFemaleMiddle AgedAgedDisease ProgressionMagnetic Resonance SpectroscopyMetabolomeMonoclonal Gammopathy of Undetermined SignificanceCase-Control StudiesBiomarkers, TumorAdult

Stichwörter der Autor:innen

Nuclear Magnetic Resonancemonoclonal gammopathy of undetermined significancemultiple myelomamultivariate analysispathway analysisserum diagnostic metabolitesunivariate analysis

Substanzen

LipoproteinsAmino AcidsBiomarkers, Tumor

Autor:innen und Institutionen

  • College of Medicine, QU Health, Qatar University, Doha 2713, Qatar.
  • Department of Health Science and Technology, Aalborg University, DK-9220 Aalborg, Denmark.
  • Department of Clinical Biochemistry, Aalborg University Hospital, DK-9000 Aalborg, Denmark.
  • Department of Clinical Medicine, Aalborg University, DK-9000 Aalborg, Denmark.
  • Biomedical Research Center (BRC), Qatar University, Doha 2713, Qatar.
  • Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, NO-7491 Trondheim, Norway.

ORCID-Profile: Shona Pedersen, Søren Risom Kristensen, Najeha Rizwana Anwardeen, Mohamed A Elrayess

Förderung

  • Obel Family Foundation
  • Danish Research Council for Independent Research

Zitieren

APA

Pedersen, S., Mikkelstrup, M. F., Kristensen, S. R., Anwardeen, N. R., Elrayess, M. A., & Andreassen, T. (2023). Serum NMR-Based Metabolomics Profiling Identifies Lipoprotein Subfraction Variables and Amino Acid Reshuffling in Myeloma Development and Progression. International Journal of Molecular Sciences, 24(15), 12275. https://doi.org/10.3390/ijms241512275

Vancouver

Pedersen S, Mikkelstrup MF, Kristensen SR, Anwardeen NR, Elrayess MA, Andreassen T. Serum NMR-Based Metabolomics Profiling Identifies Lipoprotein Subfraction Variables and Amino Acid Reshuffling in Myeloma Development and Progression. International Journal of Molecular Sciences. 2023;24(15):12275. doi:10.3390/ijms241512275

BibTeX
@article{Pedersen2023,
  author = {Pedersen, Shona and Mikkelstrup, Morten Faarbæk and Kristensen, Søren Risom and Anwardeen, Najeha Rizwana and Elrayess, Mohamed A and Andreassen, Trygve},
  title = {Serum NMR-Based Metabolomics Profiling Identifies Lipoprotein Subfraction Variables and Amino Acid Reshuffling in Myeloma Development and Progression},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {15},
  pages = {12275},
  doi = {10.3390/ijms241512275}
}
Kostenlos starten →